Author

C. Neuzillet

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 3 Organism:human· 3 Approach:biophysical modeling· 1 Assay:bulk RNA-seq· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Assay:imaging· 1

Frequent Co-Authors

J. Iovanna· 3 shared R. Nicolle· 3 shared F. Delecourt· 2 shared J. Cros· 2 shared J. Raffenne· 2 shared L. De Mestier· 2 shared M. Ayadi· 2 shared M. Richard· 2 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

J. Iovanna

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Cancer BiologybioRxivNov 16, 2023

Redefining phenotypic intratumor heterogeneity of pancreatic ductal adenocarcinoma: a bottom-up approach

M. Hilmi, F. Delecourt, J. Raffenne…·J. Cros

The paper develops an immunohistochemical panel to assess intra- and inter-tumoral heterogeneity in PDAC, identifying four distinct phenotypes with clinical implications.

DOI 10.1002/path.6398

humanprotein sequence

𝕏 PostBluesky

Cancer BiologybioRxivPreprintJan 4, 2022

PACpAInt: a deep learning approach to identify molecular subtypes of pancreatic adenocarcinoma on histology slides

C. Saillard, F. Delecourt, B. Schmauch…·J. Cros

PACpAInt uses deep learning to identify molecular subtypes of pancreatic adenocarcinoma on histology slides, revealing prognostic heterogeneity and novel subtypes.

DOI 10.1101/2022.01.04.474951

humanimaging

𝕏 PostBluesky

Cancer BiologybioRxivDec 23, 2020

Translatome-based classification reveals a dual metabolic dependency of a new tumor subtype of pancreatic cancer.

S. Shin, R. Nicolle, C. Jean…·Y. Martineau

The paper identifies a new pancreatic cancer subtype with low protein synthesis but high integrated stress response activation, linked to metabolic impairments and drug resistance.

DOI 10.1002/advs.202515740

humanbulk RNA-seq

𝕏 PostBluesky